# SUSVIMO
> **BLA761197** · Biologics License Application · Sponsor: GENENTECH INC · Approved 2021-10-22
## Drug
- **FDA Application Number:** BLA761197
- **Application type:** Biologics License Application
- **Brand name:** SUSVIMO
- **Generic name:** RANIBIZUMAB
- **Active ingredients:** RANIBIZUMAB
- **Dosage form:** SOLUTION
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** GENENTECH INC
- **Manufacturer:** Genentech, Inc.
- **First approval:** 2021-10-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761197)
---
*MORVS · CC0 1.0*